Featured Articles
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced that the U.S. Food and Drug Administration has approved Dayvigo (lemborexant) 5 mg and 10 mg for the treatment of adult patients with sleep-onset insomnia and sleep maintenance insomnia. According to Eisai, the [...]
On behalf of the American Academy of Sleep Medicine (AASM), I send warm holiday greetings to all our members and fellow sleep professionals across the U.S. and throughout the world. During the holidays, I enjoy slowing down to spend extra time with family and [...]
Health Canada, a federal department responsible for helping Canadians maintain and improve their health, issued a letter to health care professionals in June, warning them about the risk of congenital anomalies when modafinil is used during pregnancy. Modafinil is indicated to improve wakefulness in [...]
The FDA has issued a safety alert warning that serious breathing difficulties may occur in patients with respiratory risk factors who are using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR). These risk factors include the use of opioid pain medicines and other [...]
National Government Services (NGS), a CMS Medicare Contractor for Medicare jurisdictions 6 (Illinois, Wisconsin, and Minnesota) and K (Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island, and Vermont), has released a revised medical policy article (A53019) for polysomnography and sleep studies, effective Oct. 31, 2019. [...]
On the eve of another Thanksgiving Day, there is so much for which I can give thanks. I especially enjoy the opportunity to spend the holiday with friends and family. As a sleep physician, I’m thankful to have one of the greatest jobs in [...]
On Nov. 1, 2019, the Centers for Medicare & Medicaid Services (CMS) released the 2020 Medicare Physician Fee Schedule Final Rule, summarizing proposed revisions to the Physician Fee Schedule. AASM staff analyzed the final rule to determine whether CMS finalized proposals that would impact [...]
Please share the following information with your teenage patients and encourage them to enter the 2020 AASM High School Video Contest! The American Academy of Sleep Medicine invites U.S. high school students to enter the 2020 AASM High School Video Contest, which is focused [...]
DARIEN, IL – Patients and medical providers should be aware that chronic opioid use can interfere with sleep by reducing sleep efficiency and increasing the risk of sleep-disordered breathing, according to a position statement from the American Academy of Sleep Medicine. Opioid use has boomed [...]
On Nov. 13 the American Board of Internal Medicine (ABIM) announced that it anticipates offering a longitudinal assessment option for maintenance of certification (MOC) for the first time in 2022 in as many specialties as possible. The plan to develop a self-paced, longitudinal assessment [...]